...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Term sheet and enterprise valuation

TP, 

We need a buyout or a major BP partnership deal not a little co development clinical payment of trial deal, If the science is so innovative, cutting edge , futuristic and compelling than Most of the BP should be all over a major deal or buyout of Zenith, if it doesn't happen soon Management has failed to deliver and proper Enterprise valuation for an exist strategy for shareholders, if it means waiting a year to get a massive buyout I am willing to wait I just want to know details of BO discussions of a partnership, being a private enterprise they can devolve more 

Share
New Message
Please login to post a reply